Literature DB >> 21701883

Ivabradine and nightmares: a previously unreported adverse reaction.

Knut Tore Lappegård, Elisabet Nordmo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21701883     DOI： 10.1007/s00228-011-1085-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  15 in total

Review 1.  Novel If current inhibitor ivabradine: safety considerations.

Authors:  Irina Savelieva; A John Camm
Journal:  Adv Cardiol       Date:  2006

2.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

3.  Inappropriate sinus tachycardia - successful treatment with ivabradine.

Authors:  Ozlem Ozcan Celebi; Alper Canbay; Savas Celebi; Sinan Aydogdu; Erdem Diker
Journal:  Kardiol Pol       Date:  2010-08       Impact factor: 3.108

4.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

Review 5.  Drug induced nightmares--an etiology based review.

Authors:  J F Pagel; P Helfter
Journal:  Hum Psychopharmacol       Date:  2003-01       Impact factor: 1.672

6.  A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine.

Authors:  Pierre-Francois Winum; Guillaume Cayla; Madeleine Rubini; Lionel Beck; Patrick Messner-Pellenc
Journal:  Pacing Clin Electrophysiol       Date:  2009-07       Impact factor: 1.976

Review 7.  I f inhibition with ivabradine : electrophysiological effects and safety.

Authors:  Irina Savelieva; A John Camm
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum.

Authors:  Lucio Capulzini; Andrea Sarkozy; Oscar Semeraro; Gaetano Paparella; Gian Battista Chierchia; Carlo DE Asmundis; Markus Roos; Yoshinao Yazaki; Andreas Muller-Burri; Antonio Sorgente; Pedro Brugada
Journal:  Pacing Clin Electrophysiol       Date:  2009-10-10       Impact factor: 1.976

9.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

Review 10.  Beta-blockers and central nervous system side effects.

Authors:  J McAinsh; J M Cruickshank
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310
View more
  1 in total

1.  Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox database.

Authors:  Maria Hoeltzenbein; Marie-Louise Lehmann; Evelin Beck; Katarina Dathe; Christof Schaefer
Journal:  Eur J Clin Pharmacol       Date:  2021-01-26       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.